Diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy: Experience and recommendations for Mexico

Norma A. Vázquez-Cárdenas, Francisco Ibarra-Hernández, Luz B. López-Hernández, Rosa E. Escobar-Cedillo, Luis A. Ruano-Calderón, Benjamín Gómez-Díaz, Noemí García-Calderón, M. Fernanda Carriedo-Dávila, Liliana G. Rojas-Hurtado, Emilia Luna-Padrón, Ramón M. Coral-Vázquez

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Duchenne muscular dystrophy is a severe, debilitating and progressive disease that affects 1 in 3,500 live male births in the world. The diagnosis should be confirmed by genetic testing to identify the mutation in the DMD gene or muscle biopsy and immunostaining to demonstrate the absence of dystrophin. Although up to now continues to be an incurable disease, this does not mean it has no treatment. Treatment should be multidisciplinary, looking for the functionality of the patient and avoiding or correcting complications, mainly cardio-respiratory and skeletal. Many proposals have been evaluated and implemented with the aim of improving the quality of life for these patients. The longterm steroids have shown significant benefits, such as prolonging ambulation, reduce the need for spinal surgery, improve cardiorespiratory function and increase survival and the quality of life. This document presents the recommendations based on the experience of the working group and experts worldwide on the diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy. © 2013 Revista de Neurología.
Original languageAmerican English
Pages (from-to)455-462
Number of pages408
JournalRevista de Neurologia
StatePublished - 22 Nov 2013

Fingerprint

Duchenne Muscular Dystrophy
Mexico
Steroids
Quality of Life
Dystrophin
Live Birth
Genetic Testing
Walking
Therapeutics
Biopsy
Muscles
Mutation
Survival
Genes

Cite this

Vázquez-Cárdenas, N. A., Ibarra-Hernández, F., López-Hernández, L. B., Escobar-Cedillo, R. E., Ruano-Calderón, L. A., Gómez-Díaz, B., ... Coral-Vázquez, R. M. (2013). Diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy: Experience and recommendations for Mexico. Revista de Neurologia, 455-462.
Vázquez-Cárdenas, Norma A. ; Ibarra-Hernández, Francisco ; López-Hernández, Luz B. ; Escobar-Cedillo, Rosa E. ; Ruano-Calderón, Luis A. ; Gómez-Díaz, Benjamín ; García-Calderón, Noemí ; Carriedo-Dávila, M. Fernanda ; Rojas-Hurtado, Liliana G. ; Luna-Padrón, Emilia ; Coral-Vázquez, Ramón M. / Diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy: Experience and recommendations for Mexico. In: Revista de Neurologia. 2013 ; pp. 455-462.
@article{bbb3e951610241fd829a3ce5f9a44d00,
title = "Diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy: Experience and recommendations for Mexico",
abstract = "Duchenne muscular dystrophy is a severe, debilitating and progressive disease that affects 1 in 3,500 live male births in the world. The diagnosis should be confirmed by genetic testing to identify the mutation in the DMD gene or muscle biopsy and immunostaining to demonstrate the absence of dystrophin. Although up to now continues to be an incurable disease, this does not mean it has no treatment. Treatment should be multidisciplinary, looking for the functionality of the patient and avoiding or correcting complications, mainly cardio-respiratory and skeletal. Many proposals have been evaluated and implemented with the aim of improving the quality of life for these patients. The longterm steroids have shown significant benefits, such as prolonging ambulation, reduce the need for spinal surgery, improve cardiorespiratory function and increase survival and the quality of life. This document presents the recommendations based on the experience of the working group and experts worldwide on the diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy. {\circledC} 2013 Revista de Neurolog{\'i}a.",
author = "V{\'a}zquez-C{\'a}rdenas, {Norma A.} and Francisco Ibarra-Hern{\'a}ndez and L{\'o}pez-Hern{\'a}ndez, {Luz B.} and Escobar-Cedillo, {Rosa E.} and Ruano-Calder{\'o}n, {Luis A.} and Benjam{\'i}n G{\'o}mez-D{\'i}az and Noem{\'i} Garc{\'i}a-Calder{\'o}n and Carriedo-D{\'a}vila, {M. Fernanda} and Rojas-Hurtado, {Liliana G.} and Emilia Luna-Padr{\'o}n and Coral-V{\'a}zquez, {Ram{\'o}n M.}",
year = "2013",
month = "11",
day = "22",
language = "American English",
pages = "455--462",
journal = "Revista de Neurologia",
issn = "0210-0010",
publisher = "Revista de Neurologia",

}

Vázquez-Cárdenas, NA, Ibarra-Hernández, F, López-Hernández, LB, Escobar-Cedillo, RE, Ruano-Calderón, LA, Gómez-Díaz, B, García-Calderón, N, Carriedo-Dávila, MF, Rojas-Hurtado, LG, Luna-Padrón, E & Coral-Vázquez, RM 2013, 'Diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy: Experience and recommendations for Mexico', Revista de Neurologia, pp. 455-462.

Diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy: Experience and recommendations for Mexico. / Vázquez-Cárdenas, Norma A.; Ibarra-Hernández, Francisco; López-Hernández, Luz B.; Escobar-Cedillo, Rosa E.; Ruano-Calderón, Luis A.; Gómez-Díaz, Benjamín; García-Calderón, Noemí; Carriedo-Dávila, M. Fernanda; Rojas-Hurtado, Liliana G.; Luna-Padrón, Emilia; Coral-Vázquez, Ramón M.

In: Revista de Neurologia, 22.11.2013, p. 455-462.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy: Experience and recommendations for Mexico

AU - Vázquez-Cárdenas, Norma A.

AU - Ibarra-Hernández, Francisco

AU - López-Hernández, Luz B.

AU - Escobar-Cedillo, Rosa E.

AU - Ruano-Calderón, Luis A.

AU - Gómez-Díaz, Benjamín

AU - García-Calderón, Noemí

AU - Carriedo-Dávila, M. Fernanda

AU - Rojas-Hurtado, Liliana G.

AU - Luna-Padrón, Emilia

AU - Coral-Vázquez, Ramón M.

PY - 2013/11/22

Y1 - 2013/11/22

N2 - Duchenne muscular dystrophy is a severe, debilitating and progressive disease that affects 1 in 3,500 live male births in the world. The diagnosis should be confirmed by genetic testing to identify the mutation in the DMD gene or muscle biopsy and immunostaining to demonstrate the absence of dystrophin. Although up to now continues to be an incurable disease, this does not mean it has no treatment. Treatment should be multidisciplinary, looking for the functionality of the patient and avoiding or correcting complications, mainly cardio-respiratory and skeletal. Many proposals have been evaluated and implemented with the aim of improving the quality of life for these patients. The longterm steroids have shown significant benefits, such as prolonging ambulation, reduce the need for spinal surgery, improve cardiorespiratory function and increase survival and the quality of life. This document presents the recommendations based on the experience of the working group and experts worldwide on the diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy. © 2013 Revista de Neurología.

AB - Duchenne muscular dystrophy is a severe, debilitating and progressive disease that affects 1 in 3,500 live male births in the world. The diagnosis should be confirmed by genetic testing to identify the mutation in the DMD gene or muscle biopsy and immunostaining to demonstrate the absence of dystrophin. Although up to now continues to be an incurable disease, this does not mean it has no treatment. Treatment should be multidisciplinary, looking for the functionality of the patient and avoiding or correcting complications, mainly cardio-respiratory and skeletal. Many proposals have been evaluated and implemented with the aim of improving the quality of life for these patients. The longterm steroids have shown significant benefits, such as prolonging ambulation, reduce the need for spinal surgery, improve cardiorespiratory function and increase survival and the quality of life. This document presents the recommendations based on the experience of the working group and experts worldwide on the diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy. © 2013 Revista de Neurología.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84887834455&origin=inward

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84887834455&origin=inward

M3 - Article

SP - 455

EP - 462

JO - Revista de Neurologia

JF - Revista de Neurologia

SN - 0210-0010

ER -

Vázquez-Cárdenas NA, Ibarra-Hernández F, López-Hernández LB, Escobar-Cedillo RE, Ruano-Calderón LA, Gómez-Díaz B et al. Diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy: Experience and recommendations for Mexico. Revista de Neurologia. 2013 Nov 22;455-462.